Sodium-glucose cotransporter 2 inhibitors
Pro Research Analysisby 
Searched over 200M research papers
Mechanism of Action and Glucose Control with SGLT2 Inhibitors
Sodium-glucose cotransporter 2 inhibitors (SGLT2 inhibitors) are a class of medications used primarily to treat type 2 diabetes. They work by blocking SGLT2 proteins in the kidneys, which are responsible for reabsorbing glucose back into the bloodstream. By inhibiting this process, these drugs increase glucose excretion in urine (glucosuria), leading to lower blood sugar levels and a reduction in hemoglobin A1c by about 0.9–1% DaileyIII2019Fonseca-Correa2021Nair2009. This mechanism is unique compared to other diabetes medications, as it does not rely on insulin secretion or sensitivity DaileyIII2019Nair2009.
Cardiovascular and Renal Benefits of SGLT2 Inhibitors
Beyond glucose control, SGLT2 inhibitors have shown significant benefits for heart and kidney health. Large clinical trials have demonstrated that drugs like empagliflozin, dapagliflozin, and canagliflozin reduce the risk of major cardiovascular events, heart failure hospitalizations, and progression to advanced kidney disease in patients with type 2 diabetes, especially those with established cardiovascular or kidney disease Heerspink2016Cowie2021Fonseca-Correa2021+2 MORE. For every 100 patients with chronic kidney disease taking an SGLT2 inhibitor for five years, about 3–4 fewer will develop end-stage kidney disease or die from any cause compared to placebo . These benefits are thought to be related to the drugs’ effects on blood pressure, plasma volume, and kidney function Heerspink2016Fonseca-Correa2021Scheen2020.
Effects on Blood Pressure, Weight, and Metabolism
SGLT2 inhibitors also help lower blood pressure by 4–6 mmHg systolic and 1–2 mmHg diastolic, mainly due to their diuretic and natriuretic effects (increased excretion of sodium and water) DaileyIII2019Heerspink2016Fonseca-Correa2021+1 MORE. Patients often experience modest weight loss, which is attributed to the loss of calories through glucose in the urine DaileyIII2019Fonseca-Correa2021Nair2009+1 MORE. Additionally, these drugs shift metabolism from carbohydrates to lipids, increasing insulin sensitivity and promoting mild ketogenesis, which may further protect the heart and kidneys DaileyIII2019Fonseca-Correa2021Lazarte2021.
Impact on Lipid Profile
SGLT2 inhibitors have mild effects on blood lipids. Meta-analyses and clinical studies show that they slightly increase both LDL cholesterol and HDL cholesterol, but have a neutral effect on total cholesterol and triglycerides Lazarte2021Fan2023. These changes are generally considered minor and are outweighed by the significant cardiovascular and renal benefits of the drugs Lazarte2021Fan2023.
Safety and Side Effects
The most common side effects of SGLT2 inhibitors are an increased risk of genital fungal infections and mild volume depletion due to increased urination Heerspink2016Nair2009. However, serious adverse events are rare, and some studies have shown a lower risk of acute kidney injury with these medications . The risk of hypoglycemia is low, especially when SGLT2 inhibitors are used alone or with other non-insulin diabetes medications DaileyIII2019Scheen2020.
Clinical Use and Guidelines
Current diabetes management guidelines recommend SGLT2 inhibitors, especially for patients with type 2 diabetes who have atherosclerotic cardiovascular disease, heart failure, or chronic kidney disease, often after metformin Heerspink2016Cowie2021Scheen2020. Ongoing research is exploring their benefits in patients without diabetes as well .
Conclusion
SGLT2 inhibitors represent a major advancement in the treatment of type 2 diabetes, offering not only effective glucose control but also significant protection for the heart and kidneys. Their additional benefits on blood pressure, weight, and metabolism, along with a favorable safety profile, make them a valuable option for many patients with diabetes and related conditions DaileyIII2019Heerspink2016Cowie2021+6 MORE.
Sources and full results
Most relevant research papers on this topic